Skip to main content

Table 1 Analysis of 85 sera from patients with a culture confirmed Yersinia enterocolitica O:3 infection

From: Development of an LPS-based ELISA for diagnosis of Yersinia enterocolitica O:3 infections in Danish patients: a follow-up study

 

Days (median)

No of samples

IgA

IgG

IgM

IgA, IgG, IgM combined

Agglutination

Sample 1

20–104 (53)

77

37 (48%)

30 (39%)

57 (74%)

59 (77%)

45 (58%)

Sample 2

66–271 (119)

39

12 (31%)

16 (41%)

14 (36%)

20 (51%)

13 (33%)

Sample 3

164–736 (209,5)

60

16 (27%)

19 (32%)

19 (32%)

29 (48%)

13 (22%)

Sample 4

353–1053 (610,5)

44

10 (23%)

10 (23%)

9 (20%)

18 (41%)

6 (14%)

Sample 1 and/or 2

 

81

38 (47%)

33 (41%)

59 (73%)

62 (77%)

47 (58%)

Up to 36 days

20–36 (29,5)

10

9 (90%)

4 (40%)

10 (100%)

10 (100%)

6 (60%)

Up to 60 days

20–60 (44)

48

28 (58%)

20 (42%)

38 (79%)

39 (81%)

29 (60%)

61–90 days

62–88 (71,5)

32

9 (28%)

10 (31%)

20 (63%)

20 (63%)

17 (53%)

3–6 months

93–182 (124,5)

36

11 (31%)

14 (39%)

12 (33%)

19 (53%)

11 (31%)

6–12 months

183–362 (213)

61

17 (28%)

21 (34%)

21 (34%)

31 (51%)

14 (23%)

1–2 years

377–719 (473)

26

7 (27%)

7 (27%)

6 (23%)

13 (50%)

6 (23%)

2–3 years

736–1053 (896)

17

3 (18%)

3 (18%)

2 (12%)

4 (24%)

0 (0%)

  1. Number and percentages of sera producing OD-values above the cut-off when testing in an ELISA using Y. enterocolitica O:3 LPS as antigen or with tube agglutination. Patients delivered up to 4 samples following culture confirmation of Y. enterocolitica infection. No patient donated a sample for every one of the four presented time ranges